232 related articles for article (PubMed ID: 24205020)
1. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
Wang Y; Chu X; Meng X; Zou F
PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
[TBL] [Abstract][Full Text] [Related]
2. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
3. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
4. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
5. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.
Choudhury JH; Choudhury B; Kundu S; Ghosh SK
Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516
[TBL] [Abstract][Full Text] [Related]
7. Effect of Arg399Gln single-nucleotide polymorphism in
Dutta D; Abarna R; Shubham M; Subbiah K; Duraisamy S; Chinnusamy R; Anbalagan M
J Cancer Res Ther; 2020; 16(3):551-558. PubMed ID: 32719266
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
10. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
[TBL] [Abstract][Full Text] [Related]
11. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
12. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.
Dai L; Wang K; Zhang J; Lv Q; Wu X; Wang Y
Int J Cancer; 2009 Sep; 125(5):1102-9. PubMed ID: 19444915
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
Dong LM; Zhang XY; Teng H; Li MS; Wang P
Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
[TBL] [Abstract][Full Text] [Related]
15. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
17. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
Mutlu P; Mutlu M; Yalcin S; Unsoy G; Yaylaci A; Saylam G; Akin I; Korkmaz H; Gunduz U
J BUON; 2015; 20(2):540-7. PubMed ID: 26011347
[TBL] [Abstract][Full Text] [Related]
18. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Hu Z; Hu X; Long J; Su L; Wei B
Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
[TBL] [Abstract][Full Text] [Related]
20. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
Wu D; Jiang H; Gu Q; Zhang D; Li Z
Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
